Search Results 121-130 of 17385 for CLL

1. Clinical trials - Oncology (Medical)

   ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

2. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C - Mayo Clinic

   To determine the correlation between the specific subtype of MBL (CD5- MBL, atypical CLL-phenotype MBL and CLL-phenotype MBL) relative to the HCV genotype.

3. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

   This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...

4. Obinutuzumab (intravenous route) - Side effects & uses - Mayo Clinic

   Description. Obinutuzumab injection is used together with other medicines (eg, chlorambucil) to treat chronic lymphocytic leukemia (CLL).

5. Mazie Tsang, M.D. - Mayo Clinic Faculty Profiles

   Focus areas · Decision-making for older adults with advanced cancers. Dr. · Managing older adults with chronic lymphocytic leukemia (CLL). CLL mainly affects ...

6. Asher A. Chanan-Khan, M.D. - Doctors and Medical Staff - Mayo Clinic

   Chronic lymphocytic leukemia (CLL); Waldenstroms macroglobulinemia; Experimental therapeutics; Drug resistance in multiple myeloma; Novel therapeutics in ...

7. Clinical trials - Oncology (Medical)

   ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

8. Clinical trials - Oncology (Medical)

   Increasing CLL patients overall physical fitness levels, through exercise during the observation stage, may provide a realistic approach means to increase ...

9. Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   Patients must be diagnosed with CLL in accordance with International Workshop on Chronic Lymphocytic Leukemia (IWCLL) 2008 criteria that includes all of the ...

10. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Giving ibrutinib and obinutuzumab with venetoclax may work better at treating chronic lymphocytic leukemia. Participation eligibility. Participant eligibility ...